Cytori Therapeutics reported $-3779000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Baxter International BAX:US $ 911M 27M
Cerus CERS:US $ -8.98M 2.83M
Cytori Therapeutics CYTX:US $ -3.78M 0.27M
Dr.Reddys Laboratories DRRD:IN IR 11929M 275M
Genocea Biosciences GNCA:US $ -15.37M 2.37M
Haemonetics HAE:US $ 112.29M 46.15M
Infinity Pharmaceuticals INFI:US $ -12.29M 0.91M
Merrimack Pharmaceuticals MACK:US $ -577000 104K
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Northwest Biotherapeutics NWBO:US -12186000 1.59M
Starpharma Holdings Ltd SPL:AU -7931000 887K
Sun Pharmaceuticals SUNP:IN IR 21793.5M 4375.7M
Teva Pharmaceutical TEVA:IT 1.11B 176M